1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 What Is This Report About?
2.2 Electrophysiology Devices Market Segmentation
2.3 Definitions of Markets Covered in the Report
3 Electrophysiology Devices Market, United States
3.1 Electrophysiology Devices Market, United States, Revenue ($m), 2018-2033
3.1.1 Electrophysiology Ablation Catheters Market, United States, Revenue ($m), by Segment, 2018-2033
3.1.2 Electrophysiology Diagnostic Catheters Market, United States, Revenue ($m), by Segment, 2018-2033
3.1.3 Electrophysiology Lab Systems Market, United States, Revenue ($m), by Segment, 2018-2033
3.2 Electrophysiology Devices Market, United States, Volume (Units), 2018-2033
3.2.1 Electrophysiology Ablation Catheters Market, United States, Volume (Units), by Segment, 2018-2033
3.2.2 Electrophysiology Diagnostic Catheters Market, United States, Volume (Units), by Segment, 2018-2033
3.2.3 Electrophysiology Lab Systems Market, United States, Volume (Units), by Segment, 2018-2033
3.3 Electrophysiology Devices Market, United States, Average Price ($), 2018-2033
3.4 Electrophysiology Devices Market, United States, Company Share by Revenue ($m), 2024
4 Overview of Key Companies in United States, Electrophysiology Devices Market
4.1 Biosense Webster Inc
4.1.1 Company Overview
4.2 Boston Scientific Corp
4.2.1 Company Overview
4.3 Abbott Laboratories
4.3.1 Company Overview
4.4 Medtronic Plc
4.4.1 Company Overview
4.5 Siemens Healthineers AG
4.5.1 Company Overview
4.6 GE HealthCare Technologies Inc
4.6.1 Company Overview
5 Electrophysiology Devices Market Pipeline Products6 Financial Deals Landscape
6.1 Equity Offerings
6.1.1 GE HealthCare Technologies to Raise Funds in Secondary Offering of Shares
6.1.2 GE HealthCare Technologies Prices to Raise USD1.29 Billion in Upsized Secondary Offering of Shares
7 Recent Developments
7.1 Corporate Communications
7.1.1 Jul 08, 2025: Medtronic Appoints Chad Spooner as Chief Financial Officer of MiniMed
7.1.2 May 21, 2025: Medtronic Announces Leadership Change in Cardiovascular Portfolio
7.2 Financial Announcements
7.2.1 Sep 02, 2025: Boston Scientific Announces 2025 Investor Day Meeting and Conference Call Discussing Third Quarter 2025 Results
7.2.2 Jul 30, 2025: AtriCure Reports Second Quarter 2025 Financial Results; Raises Financial Outlook for 2025
7.2.3 Jul 03, 2025: Merit Medical Systems To Announce Second Quarter 2025 Results On July 30, 2025
7.2.4 Apr 17, 2025: GE HealthCare to Announce First Quarter 2025 Results on April 30, 2025
7.2.5 Feb 13, 2025: Autonomix Medical Reports Third Quarter Fiscal Year 2025 Financial Results and Provides a Corporate Update
7.2.6 Jan 13, 2025: AtriCure Reports Preliminary Results for Fourth Quarter and Full Year 2024, Provides Financial Outlook for 2025, and Announces Upcoming Analyst & Investor Day
7.2.7 Dec 12, 2024: GE HealthCare to Announce Fourth Quarter and Full Year 2024 Results on February 13, 2025
7.2.8 Nov 11, 2024: Autonomix Medical Posts Q2 Fiscal Year 2025 Results and Announces Corporate Update
7.2.9 Oct 23, 2024: Boston Scientific Reports Results for Q3 2024
7.2.10 Oct 08, 2024: Merit Medical Systems to Announce Third Quarter 2024 Results on October 30, 2024
7.2.11 Oct 08, 2024: AtriCure to Announce Third Quarter 2024 Financial Results
7.2.12 Oct 02, 2024: Boston Scientific Announces Conference Call Discussing Third Quarter 2024 Results
7.2.13 Sep 26, 2024: Integer Schedules Third Quarter 2024 Earnings Release and Conference Call for October 24, 2024
7.3 Government and Public Interest
7.3.1 Sep 02, 2025: Autonomix Medical to Present at H.C. Wainwright 27th Annual Global Investment Conference
7.3.2 Aug 21, 2025: GE HealthCare Management to Present at Upcoming Investor Conferences
7.3.3 Aug 20, 2025: AtriCure to Participate in the 2025 Wells Fargo Healthcare Conference
7.3.4 Aug 12, 2025: Integer to Present at 2025 Wells Fargo Healthcare Conference on Sept. 4
7.3.5 Jul 28, 2025: AtriCure to Participate in the Canaccord Genuity 45th Annual Growth Conference
7.3.6 May 01, 2025: Boston Scientific Announces Upcoming Investor Conference Schedule
7.3.7 Feb 10, 2025: GE Healthcare Management to Present at Upcoming Investor Conference
7.3.8 Jan 13, 2025: AtriCure Reports Preliminary Results for Fourth Quarter and Full Year 2024, Provides Financial Outlook for 2025, and Announces Upcoming Analyst & Investor Day
7.4 Legal And Regulatory
7.4.1 May 14, 2025: BetterLife Pharma Provides Scientific Update of Mechanism of Action of BETR-001 in Treatment of Psychiatric Disorders
7.4.2 Nov 19, 2024: Botanix presentation at Bell Potter Healthcare Conference
7.5 Other Significant Developments
7.5.1 Sep 25, 2024: Siemens Healthineers Announces First U.S. Installation of Ciartic Move Self-Driving Mobile C-arm
7.6 Product News
7.6.1 Aug 20, 2025: Autonomix Medical Granted New European Patent for First-In-Class Catheter-Based Technology
7.6.2 Oct 03, 2024: Harvard Bioscience to Showcase Innovative Technologies at Society for Neuroscience (SfN) Annual Meeting 2024
7.7 Strategy And Business Planning
7.7.1 Nov 07, 2024: Tianjin MasterVision Technology Receives FDA 510(k) Clearance for SDJMASTERVISION (fluoroxyfocon A) Rigid Gas Permeable Contact Lens
8 Appendix
8.1 Research Methodology
8.1.1 Coverage
8.1.2 Secondary Research
8.1.3 Primary Research
8.1.4 Market Modeling and Forecasting
8.1.5 Company Share Analysis
8.1.6 Benchmarking
8.2 the analyst Consulting
8.3 Contact the Publisher
8.4 Disclaimer
List of Tables
Table 1: Electrophysiology Devices Market, United States, Revenue ($m), USD Constant, 2018-2033
Table 2: Electrophysiology Ablation Catheters Market, United States, Revenue ($m), USD Constant, 2018-2033
Table 3: Electrophysiology Diagnostic Catheters Market, United States, Revenue ($m), USD Constant, 2018-2033
Table 4: Electrophysiology Lab Systems Market, United States, Revenue ($m), USD Constant, 2018-2033
Table 5: Electrophysiology Devices Market, United States, Volume (Units), 2018-2033
Table 6: Electrophysiology Ablation Catheters Market, United States, Volume (Units), 2018-2033
Table 7: Electrophysiology Diagnostic Catheters Market, United States, Volume (Units), 2018-2033
Table 8: Electrophysiology Lab Systems Market, United States, Volume (Units), 2018-2033
Table 9: Electrophysiology Devices Market, United States, Average Price ($), 2018-2033
Table 10: Electrophysiology Devices Market, United States, Company Share by Revenue ($m), 2024
Table 11: Electrophysiology Devices Market Pipeline Products
Table 12: GE HealthCare Technologies to Raise Funds in Secondary Offering of Shares
Table 13: GE HealthCare Technologies Prices to Raise USD1.29 Billion in Upsized Secondary Offering of Shares
Table 14: Total Number of Primary Research Participants, Cardiovascular devices Market, by Country
List of Figures
Figure 1: Electrophysiology Devices Market, United States, Revenue ($m), USD Constant, 2018-2033
Figure 2: Electrophysiology Ablation Catheters Market, United States, Revenue ($m), USD Constant, 2018-2033
Figure 3: Electrophysiology Diagnostic Catheters Market, United States, Revenue ($m), USD Constant, 2018-2033
Figure 4: Electrophysiology Lab Systems Market, United States, Revenue ($m), USD Constant, 2018-2033
Figure 5: Electrophysiology Devices Market, United States, Volume (Units), 2018-2033
Figure 6: Electrophysiology Ablation Catheters Market, United States, Volume (Units), 2018-2033
Figure 7: Electrophysiology Diagnostic Catheters Market, United States, Volume (Units), 2018-2033
Figure 8: Electrophysiology Lab Systems Market, United States, Volume (Units), 2018-2033
Figure 9: Electrophysiology Devices Market, United States, Company Share (%), 2024